All News

The study, published in the Journal of Thoracic Oncology, found that patients treated with definitive concurrent chemotherapy and radiation therapy for stage 3 non-small cell lung cancer have longer overall survival when treated by highly experienced facilities, either academic or community cancer centers.

A novel costing strategy has been used to determine the cost of care across the entire care process for benign prostate hyperplasia, according to researchers from the University of California, Los Angeles.

The 23-gene diagnostic panel called myPath Melanoma could be used in addition to microscopy to distinguish the benign form of the disease from malignant disease.

A discussion on the Supreme Court oral arguments for King v. Burwell got very heated as America's Health Insurance Plans kicked off its National Health Policy Conference in Washington, DC, on March 11.

At a time of rapid change and consolidation in healthcare, California's attorney general put conditions on the Daughters of Charity sale that would restrict Prime Healthcare's growth and limit its ability to negotiate managed care contracts.

The awards will be presented at ASCO's annual meeting to be held in Chicago in May this year.

Obamacare's tenuous toehold in Montana appears to be growing no firmer. Despite a hearing crowded with supporters of the Democratic governor's Medicaid expansion bill, Republican legislators have dealt the measure a likely death blow.

The recommendation has not come easy for Roche. Back in October 2014, NICE had rejected Gazyravo based on inconsistencies in the filing, which were then addressed by the drug manufacturer. Subsequently, NICE struck a deal with Roche to provide the drug to NHS at a reduced price.

While the PBM Express Scripts declared plans to bring cancer drug plans down, the drug manufacturers and investors aren't too worried about the high cost of some of the specialty drugs, according to this article in Bloomberg.

CMS announced the Next Generation Accountable Care Organization Model, which takes on greater performance risk but could potentially reap greater rewards.

Young adults appear to have changed their use of the emergency department since the implementation of the Affordable Care Act to reflect a more efficient use of medical care, according to a new report in the Annals of Emergency Medicine.

At a state-of-the-art facility in Thousand Oaks, California, drugmaker Amgen Inc. is perfecting the art of copying others, and it must work fast because copycats are already coming for Amgen's drugs.

Within 5 years of a breast cancer diagnosis, patients are at an increased risk of developing thyroid cancer, according to a new study, which was presented at the Endocrine Society's 97th annual meeting.

Congress came close to adopting a value-based payment formula for physicians last year, but the problem of funding the SGR, which has grown to $175 billion, prevents a solution.

Letting patients see their medical records while they're in the hospital might ease worry and confusion without extra work for doctors and nurses, a small study suggests.

Commissioned by The Leukemia and Lymphoma Society, the results of the study help make the case for placing limits on out-of-pocket costs for patients that would relieve their financial burden without a significant impact to insurers.

Just 2 therapy classes are responsible for more than half of the increase in overall prescription drug spending in the United States, reported Express Scripts.

Oregon Gov Kate Brown signed a bill shutting down the troubled, and expensive, state health insurance exchange, Cover Oregon.

A study, published in the journal Cancer, found that women with a family history of both breast and prostate cancer among first-degree relatives have an almost 2-fold increase in risk of developing breast cancer themselves.

One of the criticisms, which came from ASCO, points to the absence of consideration for patient heterogeneity that can result in physicians being penalized for providing patient-centered treatment.

Evidence-Based Oncology: Future of Incentive-Driven Pathway Adherence, developed in collaboration with Healthcare Research & Analytics (HRA), outlines what the real impact of clinical pathways are on the oncology practice and what the key drivers of clinical pathways use are for both payers and providers.

AJMC is proud to bring you an educational webinar that will provide reasons & examples on why you should engage with customers before they\'re your customers.

AJMC is proud to bring you an educational webinar that will tell how innovative data curation methods can provide well-informed, actionable business strategies for the evolving healthcare landscape.

AJMC is proud to bring you the first in our series of educational webinars to help our readers and customers better understand some of the trends, challenges and opportunities in the managed care segment

New Hampshire's waiver features premium assistance to shop on the HealthCare.gov exchange and includes a work-referral requirement. CMS resisted linking a waiver to work-related requirements more than a year ago when granting Pennsylvania's waiver.

While sunitinib failed as adjuvant treatment in advanced kidney cancer, this phase 2 study presented at the ongoing annual meeting of The Endocrine Society found that in patients with advanced thyroid cancer, sunitinib treatment resulted in median progression free survival of about 8 months. The authors think their results create sufficient evidence to initiate a phase 3 trial of the drug in thyroid cancer patients.

Kansas health regulators are working to repeal a 2002 law prohibiting the state from regulating mental health drugs used for treating Medicaid patients. Doing so could potentially save the state about $7 million.

New oncology payment models, 340B pricing and disproportionate share hospitals, and the significant difference in reimbursement rates for cancer care services are just some of the challenges faced by community oncology clinics. How do patients make informed decisions on where to go for care?

In an era when most industries easily share big, complicated digital files, healthcare still leans hard on paper printouts and fax machines.

A group of 700 independent Portland doctors, both primary care and specialty, have come together to for a new accountable care organization.